Profile
Full Name
Blueprint Medicines CorporationTicker Symbol
BPMCExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
April 30, 2015Indexes
Not includedEmployees
649Key Details
Price
$87.66(+1.82%)
Market cap
$5.60B(Mid cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$508.82M(+104.04% YoY)
Annual EPS
-$1.07(+87.22% YoY)
Next earnings date
May 2, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Blueprint Medicines doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 16, 25 Wedbush
OutperformApr 8, 25 Needham
BuyMar 17, 25 Jefferies
BuyMar 7, 25 Scotiabank
Sector OutperformMar 3, 25 Citizens Capital Markets
Market OutperformFeb 14, 25 Needham
BuyFeb 14, 25 JMP Securities
Market OutperformFeb 14, 25 HC Wainwright & Co.
BuyFeb 13, 25 Needham
BuyFeb 4, 25 JP Morgan
OverweightInstitutional Ownership
- What is the ticker symbol for Blueprint Medicines?
- Does Blueprint Medicines pay dividends?
- What sector is Blueprint Medicines in?
- What industry is Blueprint Medicines in?
- What country is Blueprint Medicines based in?
- When did Blueprint Medicines go public?
- Is Blueprint Medicines in the S&P 500?
- Is Blueprint Medicines in the NASDAQ 100?
- Is Blueprint Medicines in the Dow Jones?
- When was Blueprint Medicines's last earnings report?
- When does Blueprint Medicines report earnings?
- Should I buy Blueprint Medicines stock now?
What is the ticker symbol for Blueprint Medicines?
The ticker symbol for Blueprint Medicines is NASDAQ:BPMC
Does Blueprint Medicines pay dividends?
No, Blueprint Medicines does not pay dividends
What sector is Blueprint Medicines in?
Blueprint Medicines is in the Healthcare sector
What industry is Blueprint Medicines in?
Blueprint Medicines is in the Biotechnology industry
What country is Blueprint Medicines based in?
Blueprint Medicines is headquartered in United States
When did Blueprint Medicines go public?
Blueprint Medicines's initial public offering (IPO) was on April 30, 2015
Is Blueprint Medicines in the S&P 500?
No, Blueprint Medicines is not included in the S&P 500 index
Is Blueprint Medicines in the NASDAQ 100?
No, Blueprint Medicines is not included in the NASDAQ 100 index
Is Blueprint Medicines in the Dow Jones?
No, Blueprint Medicines is not included in the Dow Jones index
When was Blueprint Medicines's last earnings report?
Blueprint Medicines's most recent earnings report was on Feb 13, 2025
When does Blueprint Medicines report earnings?
The next expected earnings date for Blueprint Medicines is May 2, 2025
Should I buy Blueprint Medicines stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions